Catching Its Breath: University of Michigan Overturns 100-Year Dogma on Major Lung Bacterium

Imagine spending a century telling medical students that fish hate water, and you have a pretty good idea of what microbiologists have been doing since the 1920s. For over one hundred years, standard medical dogma insisted that Prevotella melaninogenica—a ubiquitous bacterium that makes up roughly 10% of the human lung microbiome—was a strict "obligate anaerobe" that drops dead the second it touches oxygen. There was just one tiny, awkward problem: it literally lives inside human lungs, the single most oxygenated organ in the entire human body.

Now, a groundbreaking study from the University of Michigan led by Dr. Ariangela Kozik has officially debunked the century-old textbook myth. By culturing clinical isolates under physiological oxygen gradients, the researchers proved that P. melaninogenica doesn't just survive oxygen; it actively consumes it.

This discovery fundamentally reshapes our understanding of respiratory health. In healthy lungs, P. melaninogenica plays a peaceful, protective commensal role. However, in patients with chronic obstructive pulmonary disease (COPD), cystic fibrosis, and severe asthma, its populations crash and are replaced by vicious pathogens like Pseudomonas aeruginosa.

Because doctors previously assumed Prevotella were accidental, inert hitchhikers washed down from saliva that couldn't possibly survive long in the airway, their metabolic activity was largely ignored in clinical trials.